103 related articles for article (PubMed ID: 30054844)
21. Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma.
Li X; Wang J; Zhang X; Zeng Y; Liang L; Ding Y
Ann Surg Oncol; 2012 Jan; 19(1):145-53. PubMed ID: 21861235
[TBL] [Abstract][Full Text] [Related]
22. Estrogen Receptor β as a Prognostic Marker of Tumor Progression in Colorectal Cancer with Familial Adenomatous Polyposis and Sporadic Polyps.
Stevanato Filho PR; Aguiar Júnior S; Begnami MD; Ferreira FO; Nakagawa WT; Spencer RMSB; Bezerra TS; Boggiss PE; Lopes A
Pathol Oncol Res; 2018 Jul; 24(3):533-540. PubMed ID: 28681123
[TBL] [Abstract][Full Text] [Related]
23. CCL18 as an independent favorable prognostic biomarker in patients with colorectal cancer.
Yuan R; Chen Y; He X; Wu X; Ke J; Zou Y; Cai Z; Zeng Y; Wang L; Wang J; Fan X; Wu X; Lan P
J Surg Res; 2013 Jul; 183(1):163-9. PubMed ID: 23433718
[TBL] [Abstract][Full Text] [Related]
24. Epidemiological study of colorectal adenoma and cancer in symptomatic patients in China between 1990 and 2009.
Chen HM; Weng YR; Jiang B; Sheng JQ; Zheng P; Yu CG; Fang JY
J Dig Dis; 2011 Oct; 12(5):371-8. PubMed ID: 21955430
[TBL] [Abstract][Full Text] [Related]
25. Colorectal mucosal expression of MSH2 as a potential biomarker of risk for colorectal neoplasms.
Sidelnikov E; Bostick RM; Flanders WD; Long Q; Seabrook ME
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2965-73. PubMed ID: 19861524
[TBL] [Abstract][Full Text] [Related]
26. Eukaryotic translation initiation factor 4E (eIF-4E) expressions are associated with poor prognosis in colorectal adenocarcinoma.
Chen YT; Tsai HP; Wu CC; Wang JY; Chai CY
Pathol Res Pract; 2017 May; 213(5):490-495. PubMed ID: 28242042
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic Features and Prognostic Factors in Alpha-Fetoprotein-Producing Colorectal Cancer: Analysis of 78 Cases.
Feng Y; Li Y; Dai W; Mo S; Li Q; Cai S
Cell Physiol Biochem; 2018; 51(5):2052-2064. PubMed ID: 30522102
[TBL] [Abstract][Full Text] [Related]
28. XPF expression and its relationship with the risk and prognosis of colorectal cancer.
Hu H; Jing J; Lu X; Yuan Y; Xing C
Cancer Cell Int; 2021 Jan; 21(1):12. PubMed ID: 33407486
[TBL] [Abstract][Full Text] [Related]
29. [Expression of CD10 in cancer-associated fibroblasts and its effect on initiation and progression of colorectal carcinoma].
Zhu Y; Zheng JJ; Yang F; Nie QQ; Zhu ZL; Deng H
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):859-865. PubMed ID: 28056302
[No Abstract] [Full Text] [Related]
30. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Correlation Between MFG-E8 Expression Level and Colorectal Cancer.
Jia M; Yao H; Chen C; Wang Y; Wang H; Cui T; Zhu J
Arch Med Res; 2017 Apr; 48(3):270-275. PubMed ID: 28923329
[TBL] [Abstract][Full Text] [Related]
32. Significance of mRNA and protein expression of MAC30 in progression of colorectal cancer.
Zhao ZR; Zhang LJ; He XQ; Zhang ZY; Zhang F; Li F; Pei YB; Hu YM; Wang MW; Sun XF
Chemotherapy; 2011; 57(5):394-401. PubMed ID: 22024687
[TBL] [Abstract][Full Text] [Related]
33. Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis.
Yusup A; Huji B; Fang C; Wang F; Dadihan T; Wang HJ; Upur H
World J Gastroenterol; 2017 Jan; 23(1):110-120. PubMed ID: 28104986
[TBL] [Abstract][Full Text] [Related]
34. [Expression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissues].
Lin MX; Wen ZF; Feng ZY; He D
Ai Zheng; 2008 Dec; 27(12):1321-6. PubMed ID: 19080002
[TBL] [Abstract][Full Text] [Related]
35. Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression.
Toyoda A; Kawana H; Azuhata K; Yu J; Omata A; Kishi H; Higashi M; Harigaya K
Int J Oncol; 2009 Jan; 34(1):53-60. PubMed ID: 19082477
[TBL] [Abstract][Full Text] [Related]
36. Deleted in malignant brain tumor 1 is a novel prognostic marker in colorectal cancer.
Park HS; Kim BC; Yeo HY; Kim KH; Yoo BC; Park JW; Chang HJ
Oncol Rep; 2018 May; 39(5):2279-2287. PubMed ID: 29498404
[TBL] [Abstract][Full Text] [Related]
37. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
[TBL] [Abstract][Full Text] [Related]
38. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
39. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer.
Mudduluru G; Medved F; Grobholz R; Jost C; Gruber A; Leupold JH; Post S; Jansen A; Colburn NH; Allgayer H
Cancer; 2007 Oct; 110(8):1697-707. PubMed ID: 17849461
[TBL] [Abstract][Full Text] [Related]
40. High expression of growth factor receptor-bound protein 14 predicts poor prognosis for colorectal cancer patients.
Yang P; Wei J; Li W; He F; Zeng S; Zhang T; Sun Z; Cao J
Biotechnol Lett; 2016 Jun; 38(6):1043-7. PubMed ID: 26965150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]